ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00803868
Recruitment Status : Terminated (The DSMB recommended that the study be stopped as a result of concerns regarding safety and intolerability and insufficient evidence of efficacy.)
First Posted : December 8, 2008
Last Update Posted : July 24, 2012
Sponsor:
Collaborators:
Friedreich's Ataxia Research Alliance
Pfizer
Information provided by (Responsible Party):
University of South Florida

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Actual Primary Completion Date : May 2010
  Actual Study Completion Date : May 2010

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 April 18, 2018
May 14, 2018